Webinar
The vein-to-vein supply chain: Designing zero-failure courier networks for cell and gene therapy
Cell and gene therapies are redefining what is possible in medicine — but they are also redefining the stakes of supply chain execution. In a vein-to-vein model, every shipment represents a single patient, a narrow time window, and an irreversible outcome. Unlike traditional pharmaceuticals, there is no inventory buffer, no reshipment, and no margin for error.
Key highlights
- How deterministic planning helps align every critical activity
- Why resilient courier networks are built with redundancy by design
- What sets an elite, cell and gene therapy-specific network apart
- How real-time visibility and 24/7 control tower intervention support proactive action
- Why end-to-end control matters
Speakers:
Eric Schier, Senior Manager, Personalized Supply Chain, Cencora World Courier
Louis Cicchini, Senior Director, Scientific Affairs and Strategic Partnerships (CGT), Cencora
Matthew Lakelin, Head of Consultancy Services, Trakcel
Michael Aitken, Customer Success Project Manager, Cencora World Courier
Tassadaque Masood, Customer Success Project Manager, Cencora World Courier
Watch the recording now
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
